INE03Q201024
INE03Q201024
ALIVUS LIFE SCIENCES LTD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 |
|---|---|---|---|
Market & Enterprise Value | |||
Market Cap | 162.83B EUR | 141.97B EUR | 119.39B EUR |
Enterprise Value | 155.56B EUR | 141.97B EUR | 119.93B EUR |
Valuation Multiples | |||
Trailing P/E | 27.05x | 23.88x | 20.71x |
Forward P/E | 21.12x | -- | -- |
Price to Sales | 6.29x | 5.45x | 4.57x |
Price to Book | 4.89x | -- | 3.58x |
EV/Revenue | 6.01x | 5.45x | 4.59x |
EV/EBITDA | 18.56x | 15.81x | 13.75x |
Price to FCF (P/FCF) | -- | -- | -- |
EV/FCF | -- | -- | -- |
FCF Yield | -- | -- | -- |